oAlert.pl
WARNING: RECALLED PRODUCT
PL EN

Tadalafil Aurovitas

Tests by the National Medicines Institute showed that the product does not meet quality requirements due to a negative result for the parameter “release of tadalafil within 15 minutes”, which may mean improper release of the active substance from the tablet. Potential effects: lack of treatment efficacy.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

Tadalafil Aurovitas
Risk Level
Medium
Manufacturer
Aurovitas Pharma Polska sp. z o.o., ul. Sokratesa 13D lokal 27, 01-909 Warszawa
Batch Number
TGSD21011-A
EAN Code
05909991392123
Recall Date
09.10.2023
View official statement

Important Information

What You Should Know

Recommendations

Do not use this medicinal product until the matter is clarified; patients should verify the name and strength of the medicine and consult a doctor or pharmacist regarding further therapy.

Actions Taken

Distribution of the medicinal product Tadalafil Aurovitas 20 mg, film-coated tablets, has been suspended throughout the country, with the decision given immediate enforceability.

Need Help?

If you feel unwell after consuming this product, contact your doctor or call the poison control center.

FAQ

Frequently Asked Questions

Is this product safe to consume?
No. This product has been recalled due to: Tests by the National Medicines Institute showed that the product does not meet quality requirements due to a negative result for the parameter “release of tadalafil within 15 minutes”, which may mean improper release of the active substance from the tablet. Potential effects: lack of treatment efficacy.
What should I do if I already bought this?
Stop using the product immediately. Return it to the store for a full refund. If you consumed it and feel unwell, contact your doctor.
Which batches are affected?
Affected batch numbers: TGSD21011-A

Related

Other Recalled Products